Mylan Recalls 15 Batches of Valsartan Globally, for the Treatment of Hypertension

Shots:

• Mylan has recalled globally, 6 lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), 7 lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths) and 2 lots of Valsartan and Hydrochlorothiazide Tablets, USP (320mg/25mg strength) , detected with traces of N-nitrosodiethylamine (NDEA)
• The voluntarly recall is done for the lots of Valsartan, distributed between Mar, 2017 and Nov, 2018. European Union authorities has already ban sales of valsartan few days’ back
• Valsartan is a combination of amlodipine or hydrochlorothiazide indicated for the treatment of high blood pressure, heart failure and in reduction of cardiovascular mortality

Click here to read full press release/ article | Ref: Mylan | Image: Daily Post India